DADC
AHCO icon

D.A. Davidson & Co’s AdaptHealth AHCO Stock Holding History

D.A. Davidson & Co’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40,293
Closed -$1.48M – 1189
2021
Q1 		$1.48M Buy
40,293
+1,360
+3% +$48K 0.02% 471
2020
Q4 		$1.46M Buy
+38,933
New +$1.2M 0.02% 415

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.A. Davidson & Co's AHCO Position: Q2 2021 in Review

D.A. Davidson & Co sold out of AdaptHealth (AHCO) in Q2 2021, closing a stake of 40,293 shares — an estimated $1.48M sold.

D.A. Davidson & Co first reported a position in AHCO in Q4 2020 and held it in 2 quarters. The position peaked at $1.48M in Q1 2021. 137 funds tracked by Wall St. Rank hold AHCO as of Q2 2021.

  • D.A. Davidson & Co reported no remaining AdaptHealth position as of Q2 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 40,293 AdaptHealth shares in Q2 2021, an estimated $1.48M.
  • D.A. Davidson & Co first reported a position in AdaptHealth in Q4 2020 and held it in 2 quarters.
  • D.A. Davidson & Co's AdaptHealth position peaked at $1.48M in Q1 2021.
  • 137 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2021.

Based on D.A. Davidson & Co's 13F filing for Q2 2021, filed 10 Aug 2021.